SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

CTech’s Book Review: What strategy really is and why so many organizations get it wrong

British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”

The end-of-year tech layoffs are not a crisis - they mark a paradigm shift

MSC denies interest in acquiring ZIM

Buzz

Most popular

Daily

Weekly

1

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

2

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

3

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

4

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

5

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

Pharmaceuricals

3 stories about Pharmaceuricals

Closure of another criminal case will help Teva's new CEO to focus on return to growth

22.08.23|Sophie Shulman

The pharmaceutical company has reached a compromise after being suspected of price-fixing with other generic drug manufacturers in the US. In the first four years, it will pay $22.5 million and in 2028 - $135 million. In addition, the company will donate two drugs worth $50 million to humanitarian organizations

ריצ'רד פרנסיס מנכ"ל טבע החדש על רקע אתר חברת טבע בכפר סבא

Schultz kept Teva away from the abyss, but couldn't find a runway to growth

22.11.22|Sophie Shulman

Kare Schultz, who served as CEO of the pharmaceutical company for the past five years, has left the company a year early after amassing a salary of more than $100 million. His replacement, Richard Francis, is taking over with less debt and less legal issues, but with the big challenge of creating new growth engines

United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal

30.04.18|Amarelle Wenkert

In 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics